Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment
Primary Purpose
Infertility, Overweight and Obesity, Weight Loss
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Systematic weight loss intervention
Sponsored by
About this trial
This is an interventional treatment trial for Infertility focused on measuring female infertility, male infertility, life style intervention, vaginal microbiome, synthetic endocrine disrupting chemicals, EDCs, DNA fragmentation index, DFI, gene expression
Eligibility Criteria
Inclusion Criteria:
- BMI>30
- Referred to The Fertility Clinic, Zealand Region
Exclusion Criteria:
- Unable to speak and read Danish
Sites / Locations
- The Fertility Clinic, Zealand University Hospital
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Intervention
Arm Description
Systematic weight loss intervention
Outcomes
Primary Outcome Measures
Weight loss
The change in weight (in kilograms) from baseline to the 6 month
Secondary Outcome Measures
Change in the semen quality 1
The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm count (mill/ml),
Change in the semen quality 2
The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm concentration (ml)
Change in the semen quality 3
The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm motility (mill/ml)
Change in the semen quality 4
The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm morphology (percent)
Change in the DNA fragmentation index (DFI)
The change in DNA fragmentation index is measured by SPZlab using the SDI®-test
Change in the vaginal microbiome
The change in the vaginal microbiome will be investigated at Statens Serum Institute (SSI), measured by PCR
Change in the occurence of synthetic endocrine disruption chemicals (EDCs)
The change in the occurrence of synthetic endocrine disruption chemicals (EDCs) endometrium is measured by The Department of Growth and Reproduction at Rigshospitalet by using LC-MS/MS analyze
Change in MicroRNA
The change in MicroRNA will be measured froom blood samples and is is analysed by Department of Science and Environment, RUC
Change in the gene expression of gene involved in implantation
The change in the gene expression in the endometrium is analysed by Department of Science and Environment, RUC
Numbers of achieved pregnancy
Both biochemical and clinical
Numbers of life births
Life birth
Full Information
NCT ID
NCT04721938
First Posted
June 16, 2020
Last Updated
January 23, 2023
Sponsor
Zealand University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04721938
Brief Title
Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment
Official Title
Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
May 1, 2020 (Actual)
Primary Completion Date
April 27, 2022 (Actual)
Study Completion Date
April 27, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zealand University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The detrimental effect of overweight and obesity on fecundity has been well documented.
The investigators wish to investigate the intervention program for weight loss before fertility treatment.
Subsequently to gain knowledge on the effect of overweight/obesity and weight loss on the vaginal microbiome, on DNA damage on sperm cells, on the occurrence of endocrine disruptors in the endometrium, and on the gene expression in the endometrium.
Detailed Description
Purpose and aim of the study The Fertility Clinic at Zealand University Hospital wishes to introduce a new care concept: 'Healthy Parents - Healthy Children´ with the purpose of changing the behaviours of infertile men and women towards a healthier life style now and for future generations.
The Zealand Region includes areas of significant deprivation compared to Copenhagen and has a higher prevalence of obesity and poor diet.
These inequalities generate socio-demographic and long-term health challenges, decrease the chance of becoming pregnant and increase risk of life style related diseases for parents and their offspring in the long term.
The waiting time before fertility treatment (12 months in the region) represents a unique window of opportunity to encourage long-term life style changes. The aforementioned reasons initiated the planned Preconception Clinic 'Healthy Parents - Healthy Children´.
The Preconception Clinic utilises waiting list time to optimise parental health prior to conception. We will provide weight loss interventions aimed at helping the patients to a healthier lifestyle, an increased chance of conception and a decreased risk of life style diseases for themselves and their future offspring.
Purpose of study:
Patient weight loss of at least 10% at the end of intervention and at annular follow up until 5 years.
Study population: Sub-fertile population referred to the Fertility Clinic Region Zealand due to infertility.
Inclusion criteria:
20 women and 20 men with a BMI>30, age 18-40 years.
Exclusion criteria:
Inability to understand the written and oral information.
Baseline and end of intervention-sampling:
Blood tests (metabolic markers), blood tests for Biobank and for miRNA biomarkers
Urine sample
Women: Endometrial biopsy and vaginal swab for microbiome testing
Men: Sperm sample
Intervention: Weight reduction through life style changes in diet and exercise by the following means:
Counselling with a Nutritionist Nurse on diet and exercise.
Online smartphone coaching program (LifeSum-App)
Motivational and adjustment dialogue and counselling with Nutritionist Nurse including anthropometric measures every month.
Primary endpoint: Weight loss of at least 10%.
Anticipated impact The aim of this study is to find a feasible intervention that can change adverse life styles in a preconception setting. Elements from the weight loss intervention can be incorporated to the broader community, for instance as Preconception weight loss packages in the local municipalities, aimed at optimizing health before conception in the general fertile population.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility, Overweight and Obesity, Weight Loss, Vaginal Flora Imbalance, DNA Damage
Keywords
female infertility, male infertility, life style intervention, vaginal microbiome, synthetic endocrine disrupting chemicals, EDCs, DNA fragmentation index, DFI, gene expression
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Prospective cohort study
Masking
None (Open Label)
Allocation
N/A
Enrollment
45 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Other
Arm Description
Systematic weight loss intervention
Intervention Type
Behavioral
Intervention Name(s)
Systematic weight loss intervention
Intervention Description
Weight reduction through life style changes in diet and exercise by the following means:
Counselling with a Nutritionist Nurse on diet and exercise
Online Smartphone coaching program (Life-sum App)
Motivational and adjustment dialogue and counselling with Nutritionist Nurse including anthropometric measures every month
Primary Outcome Measure Information:
Title
Weight loss
Description
The change in weight (in kilograms) from baseline to the 6 month
Time Frame
6 month
Secondary Outcome Measure Information:
Title
Change in the semen quality 1
Description
The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm count (mill/ml),
Time Frame
6 months
Title
Change in the semen quality 2
Description
The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm concentration (ml)
Time Frame
6 months
Title
Change in the semen quality 3
Description
The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm motility (mill/ml)
Time Frame
6 months
Title
Change in the semen quality 4
Description
The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm morphology (percent)
Time Frame
6 months
Title
Change in the DNA fragmentation index (DFI)
Description
The change in DNA fragmentation index is measured by SPZlab using the SDI®-test
Time Frame
6 months
Title
Change in the vaginal microbiome
Description
The change in the vaginal microbiome will be investigated at Statens Serum Institute (SSI), measured by PCR
Time Frame
6 months
Title
Change in the occurence of synthetic endocrine disruption chemicals (EDCs)
Description
The change in the occurrence of synthetic endocrine disruption chemicals (EDCs) endometrium is measured by The Department of Growth and Reproduction at Rigshospitalet by using LC-MS/MS analyze
Time Frame
6 month
Title
Change in MicroRNA
Description
The change in MicroRNA will be measured froom blood samples and is is analysed by Department of Science and Environment, RUC
Time Frame
6 months
Title
Change in the gene expression of gene involved in implantation
Description
The change in the gene expression in the endometrium is analysed by Department of Science and Environment, RUC
Time Frame
6 months
Title
Numbers of achieved pregnancy
Description
Both biochemical and clinical
Time Frame
Gestational week 4-8
Title
Numbers of life births
Description
Life birth
Time Frame
From 9 month after inclusion
Other Pre-specified Outcome Measures:
Title
Blood pressure (Systolic and Diastolic)
Time Frame
6 months
Title
Metabolic and cardiovascular marker (blood sample) 2
Description
The change in: Hemoglobin (mmol/L
Time Frame
6 months
Title
Metabolic and cardiovascular marker (blood sample) 3
Description
alanine Aminotransferase (ALT)(U/L)
Time Frame
6 months
Title
Metabolic and cardiovascular marker (blood sample) 4
Description
cholesterol (mmol/L)
Time Frame
6 months
Title
Metabolic and cardiovascular marker (blood sample) 5
Description
triglycerides (mmol/L)
Time Frame
6 months
Title
Metabolic and cardiovascular marker (blood sample) 6
Description
HbA1c (mmol/mol (IFCC)
Time Frame
6 months
Title
Metabolic and cardiovascular marker (blood sample) 7
Description
creatinine (µmol/L)
Time Frame
6 months
Title
Metabolic and cardiovascular marker (blood sample) 8
Description
fasting glucose level (mmol/L (eAG))
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
BMI>30
Referred to The Fertility Clinic, Zealand Region
Exclusion Criteria:
Unable to speak and read Danish
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne Lis Mikkelsen, MD, PhD
Organizational Affiliation
The Fertility Clinic, Zealand University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
The Fertility Clinic, Zealand University Hospital
City
Køge
Country
Denmark
12. IPD Sharing Statement
Learn more about this trial
Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment
We'll reach out to this number within 24 hrs